Miocardial Mass

ru.medsoftpro.miocardialmass

View detailed information for Miocardial Mass — ratings, download counts, screenshots, pricing and developer details. See integrated SDKs and related technical data.

Total installs
532(532)
Rating
unknown
Released
November 5, 2023
Last updated
January 1, 1970
Category
Medical
Developer
medsoftpro.ru
Developer details
Name
medsoftpro.ru
E-mail
admin@medsoftpro.ru
Website
unknown
Country
Russia
Address
unknown
Android SDKs
Miocardial Mass Header - AppWisp.com

Screenshots

Miocardial Mass Screenshot 1 - AppWisp.com
Miocardial Mass Screenshot 2 - AppWisp.com
Miocardial Mass Screenshot 3 - AppWisp.com
Miocardial Mass Screenshot 4 - AppWisp.com

Description

Left ventricular mass is an important determinant of diagnosis and prognosis in patients with heart disease (cardiovascular morbidity and mortality) in specific for determination of severity and type of cardiac hypertrophy.

The parameters involved are summarised below:

LVEDD: Left ventricular end-diastolic dimension;
IVSd: Interventricular septal thickness at end-diastole;
PWd: Posterior wall thickness at end-diastole;
LVMI: Left ventricular mass index;
RWT: Relative wall thickness;
BSA: Body surface area using the Mosteller formula.

The formulas used are the following:

LV Mass = 0.8 x (1.04 x (((LVEDD + IVSd +PWd)3 - LVEDD3))) + 0.6
LVMI (LV Mass Indexed to Body Surface Area) = LV Mass / BSA
RWT (Relative Wall Thickness) = 2 x PWd / LVEDD

For BSA, Mosteller’s formula is employed: BSA = (((Height in cm) x (Weight in kg))/ 3600)½

Left ventricular mass (LVM) can be directly determined using cardiac magnetic resonance (CMR) and is known to increase in proportion to overall body size and differs by gender:

Individuals with LV hypertrophy were found to be at 2.7 times greater risk for cardiac events, such as myocardial infarction or coronary heart disease death, (over 15 years) than individuals without LV hypertrophy.